{"name":"Shanghai Huaota Biopharmaceutical Co., Ltd.","slug":"shanghai-huaota-biopharmaceutical-co-ltd","ticker":"","exchange":"","domain":"shanghaihuaotabiopharmaceutical.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPdk1rcHIwdnVBb2hiUUxFV3VDSmQtQ3Bnejk1VW1DRlBRNUhIZlo4ZXpFNlQwZ3JvN1RHY21yNjktMFdqQ2VRUGxUb2JYbkJKLVUzbWlIejhfVHctWXR0MHZKN3J3QnhaZkRLSDFpME9uWnJkREg1ZHE2NDd3UnE0S2FyRC1pMVp3cEo0T3gxRE1aUm1lWDZZT01NcE5nQ3o5Ry1JYW9DRWlrejNjVzdPa0Nfa0IzLWVWSml4cTltMWdlRkpyQ3VnUWdMS0Nab0tRSmVWdmRhLVpwbW9pZHQxX0J6U0kwcXQ3?oc=5","date":"2026-03-27","type":"deal","source":"marketscreener.com","summary":"Almirall Strengthens China Innovation Strategy with New Biopharma Collaboration Focused on Dermatology Treatments - marketscreener.com","headline":"Almirall Strengthens China Innovation Strategy with New Biopharma Collaboration Focused on Dermatology Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNbURGeFBVM19lWjJINGlwR01HamQ5X2traTA5bllxU0gyWkd6M21MeElyZXhHTzR2LUhvZ0tsbmNzZXVoVFp0bTc0a1pNZmxDaDFNTkxXT2RWNVpYZG5CZWpBYWNGNTVPVUVGQzJwYUY2YWpTb2hWMGJDSU5tUE9OMmlHOHNScHZDM3ZZRE5YXzFRTXZzT1BkYVFKWUlNN2g1YTh1aHJKN1h3eTJ2cTFFdzdVbnVHV05EWDQ0SVB6VEZDOFdkQzU2QUhyQXRXT3BmbDY0eDllY0R6LUhNaHo0dkU0dWtNUjJ5OGFteEdSUzM4SWlZVVRnX2ZDUWFMZmRKVmZXRllhZDNHN3QzLVRabWZERlhTV0JCTWdaQ1JUdmpqbkY5OHpNb053SUdRUQ?oc=5","date":"2025-10-23","type":"trial","source":"GlobeNewswire","summary":"Hidradenitis Suppurativa Clinical Trial Analysis: Key - GlobeNewswire","headline":"Hidradenitis Suppurativa Clinical Trial Analysis: Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNbzZ6UmtYRTZ2dEF2WjZrREVfTjNpZm5TVmlEdW5pb0FJUzNxS3ZhaHJlR3A5MG5lWV9PVUVsUFBtSTk2NFR1bzJnaW1aZ3daYkh1VlI3ZDdsNE44aHZWOHlhTkR1U1VIdU9mR1laOW10WTAwTU8yaTJIWURVcm9hY1FybFVWMGRLN01MY2hnaXdBdw?oc=5","date":"2024-11-25","type":"pipeline","source":"Frontiers","summary":"CD73: agent development potential and its application in diabetes and atherosclerosis - Frontiers","headline":"CD73: agent development potential and its application in diabetes and atherosclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOcXZBVUk3R2g1NFM1cng0VnkxQ2pJNGRsQmtEWHFWUUdyeS1uV0NzT2x1dGRrelVTNHpZY0QyNkV2OTlOZnpCUkFPRHVlUndlQzlVYjFFeU5hb3IwR1dobENaNmRaQlBUZXY0MHVYQUktaV8yalRyWVdQSG9PYTd2NExabXE2c2tGRkpnSHpyQ2JJQUk?oc=5","date":"2021-03-16","type":"trial","source":"Frontiers","summary":"A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects - Frontiers","headline":"A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}